176 related articles for article (PubMed ID: 31331400)
1. IL-22 production of effector CD4
Dolff S; Scharpenberg C; Specker C; Kribben A; Witzke O; Wilde B
Eur J Med Res; 2019 Jul; 24(1):24. PubMed ID: 31331400
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
3. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
5. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
Oster C; Wilde B; Specker C; Sun M; Kribben A; Witzke O; Dolff S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514450
[TBL] [Abstract][Full Text] [Related]
6. Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Feldkamp T; Jun C; Mitchell A; Hua F; Specker C; Kribben A; Witzke O; Wilde B
Scand J Rheumatol; 2014; 43(4):307-13. PubMed ID: 25088926
[TBL] [Abstract][Full Text] [Related]
7. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.
Qin WZ; Chen LL; Pan HF; Leng RX; Zhai ZM; Wang C; Li RJ; Wang S; Wang HP; Ye DQ
Clin Exp Med; 2011 Dec; 11(4):245-50. PubMed ID: 21487830
[TBL] [Abstract][Full Text] [Related]
8. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.
Dolff S; Abdulahad WH; Westra J; Doornbos-van der Meer B; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011; 13(5):R157. PubMed ID: 21959034
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
[TBL] [Abstract][Full Text] [Related]
11. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
Lin J; Yu Y; Ma J; Ren C; Chen W
Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
[TBL] [Abstract][Full Text] [Related]
12. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
Abo-Elenein A; Shaaban D; Gheith O
Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
[TBL] [Abstract][Full Text] [Related]
13. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
14. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
16. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
17. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
[TBL] [Abstract][Full Text] [Related]
18. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2017 Apr; 69(4):808-813. PubMed ID: 27992687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
